Chlamydia test kit

COVID-19pneumoniafor antibodies

It applies the chemiluminescent immunosassay (CLIA) for the qualitative detection of SARS-COV-2 antibody in serum or plasma. Features Comprehensive solution: Reagent kits for both IgG and IgM tests for SARS-CoV-2 can provide comprehensive solution for the detection of COVID-19. Patented design: With strong social responsibility and professional R&D team, we made independent development of raw materials and stable supply for new assays within 1 month High specificity: Anti-interference to Legionella pneumococcal, mycoplasma pneumonia, chlamydia pneumonia, adenoviruses, respiratory syncytial viruses, influenza A, influenza B and para-flu viruses 1, 2 and 3, etc. Speed: Up to 1200 T/H can be achieved by our iFlash series CLIA analyzers (iFLash 1800: 180 T/H; iFlash 3000: 300 T/H, iModule: up to 1200 T/H).